Study highlights potential of p-tau217 assays in Alzheimer’s clinical trials and diagnosis Post author: Post published:March 14, 2024 Post category:uncategorized The performance of two commercial phospho-tau217 (p-tau217) assays. You Might Also Like New clinical trial offers hope for patients with rare immune disease IgG4-RD November 18, 2024 Immune cells play a key role in movement control and metabolic balance December 4, 2024 Review of Oregon’s assisted dying law finds significant data gaps October 4, 2023